This morning President and CEO of Ardent Health Systems and Chairman of FAH, David T. Vandewater participated in the Health Affairs briefing panel event, “Provider Consolidation in Health Care.” The panel examined new papers being released on the subject of hospital realignment and its impact on the health care system. This topic is timely and important, as we in the health care industry find ourselves at a critical juncture: we are witnessing a marked transformation in the delivery system, following four years of historically low growth in spending with health care price growth holding at near-historic lows.
A lot has been said about clinical integration as the starting point for transformative payment and delivery reform that yields greater efficiency and higher quality care. Recent studies and papers show that hospital realignment can bring vast benefits to the patients and communities they serve while also sustaining investment in infrastructure, HIT and other technologies. Realignment allows hospitals to maintain their presence in their communities by offering access to a wide range of services and preventing provider closures. In fact, in his comments this morning, Vandewater said that he oversaw 30 realignments during his professional career, all of which were done with the intention of preserving or expanding patient access to care in a community.
We at FAH continue to be troubled by the generally-accepted notions tied to provider realignment, like the helpless private insurer in the marketplace against hospitals pursuing realignment. That concept is particularly ironic when you consider that recent studies have shown:
- * Hospital realignment has created more competitive health care markets
- * The insurance industry has undergone a massive amount of consolidation
- * These insurer consolidations have yielded:
- * an increase in insurer market power
- * a national scenario where in 45 states, one or two insurance companies control 50% or more of the market share
At this morning’s panel, Vandewater pointed out that another of the most commonly cited misconceptions is that provider realignment has led to excessive price increases. The reality: price growth in health care generally, including hospitals, has been in a steady decline for years. And this decline, which remains near historic lows, has occurred during the same period in which there has been a great deal of hospital consolidation.
Why the misconception on price? Most of the studies cited in support of the notion that provider consolidation leads to excessive price increases rely on twenty year old data that are not relevant to today’s dynamic payment and delivery system.
Thankfully, several leading voices in the industry are starting to see the light. Just this month, Altarum noted in its report on health care prices:
“While analysts continue to express concern about the potential pricing power from provider consolidation there is, as yet, scant evidence of this.”
In addition, we are seeing new evidence that properly assesses the contemporary realignment landscape. Earlier this year, the FAH commissioned a report by the Center for Healthcare Economics and Policy that assessed 75 studies and 36 primary sources spanning the last 15 years. This analysis challenged the conventional wisdom about the negative impact of consolidation, finding that the vast majority of mergers do not impede market competition—but rather create more competitive health care markets—and saw no statistical correlation between realignment and pricing.
Vandewater and those of us working with hospital systems see a reality far more akin to that of what FTI, and others in the industry are discussing. The costs of running a hospital, of meeting the demands of regulators, patients and payers continue to escalate; and these costs are increasingly out-of-reach for small and mid-size stand-alone hospitals and systems. As a result, mergers, consolidation, realignments and other innovations are necessary for hospital survival, and to preserve patient access to care.
While this transformation unfolds amidst an era of slower growth in health care spending and near-historic low price growth, we must let the markets function and avoid the rush to regulate. We are already seeing strong signals of the market responding as insurers impose narrow networks, reference pricing, and compete in public and private exchanges. These changes are part of the push and pull of the marketplace.
And as more substantive discussions occur on this issue like today’s Health Affairs session, we will see more evidence of contemporary realignment which benefits patients and communities across the country with high quality health care at lower cost and improved outcomes.